Multi-Drug Resistant (MDR) TB Cost Effectiveness Tool

Tool

Multi-Drug Resistant TB is a major problem in many countries. Cases can be difficult to find and hard and expensive to treat. This tool provides a simple way for managers to compare the cost-effectiveness of different diagnostic and treatment strategies (e.g. hospitalized versus ambulatory treatment systems). 

The tool is in Microsoft Excel and is designed to be used by TB Program Managers at national and sub-national levels. It has a users’ guide, is user-friendly and transparent and modifications can be made by the user. The tool was developed by MSH for USAID’s TB CARE Project in Indonesia but can be used in any country.

More Information

Contact us at fintools@msh.org